A detailed history of Israel Englander (Millennium Management LLC) transactions in Cytokinetics Inc stock. As of the latest transaction made, Millennium Management LLC holds 50,000 shares of CYTK stock, worth $2.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,000
Previous 57,900 13.64%
Holding current value
$2.78 Million
Previous $4.06 Million 33.26%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$63.75 - $108.06 $24.8 Million - $42 Million
-388,431 Reduced 32.39%
810,910 $56.9 Million
Q4 2023

Feb 14, 2024

BUY
$26.88 - $83.49 $18.4 Million - $57 Million
682,876 Added 132.22%
1,199,341 $100 Million
Q2 2023

Aug 14, 2023

BUY
$32.62 - $40.75 $9.58 Million - $12 Million
293,770 Added 131.92%
516,465 $16.8 Million
Q1 2023

May 15, 2023

BUY
$33.36 - $45.71 $1.16 Million - $1.59 Million
34,726 Added 18.47%
222,695 $7.84 Million
Q4 2022

Feb 14, 2023

SELL
$35.77 - $51.11 $508,077 - $725,966
-14,204 Reduced 7.03%
187,969 $8.61 Million
Q3 2022

Nov 14, 2022

BUY
$38.54 - $54.52 $4.64 Million - $6.57 Million
120,431 Added 147.33%
202,173 $9.8 Million
Q2 2022

Aug 15, 2022

BUY
$33.93 - $48.92 $2.33 Million - $3.36 Million
68,637 Added 523.75%
81,742 $3.21 Million
Q1 2022

May 16, 2022

SELL
$29.74 - $46.0 $6.68 Million - $10.3 Million
-224,702 Reduced 94.49%
13,105 $482,000
Q4 2021

Feb 14, 2022

SELL
$34.35 - $46.38 $9.35 Million - $12.6 Million
-272,180 Reduced 53.37%
237,807 $10.8 Million
Q3 2021

Nov 15, 2021

BUY
$18.54 - $35.74 $1.08 Million - $2.08 Million
58,105 Added 12.86%
509,987 $18.2 Million
Q2 2021

Aug 16, 2021

SELL
$19.79 - $26.99 $9.28 Million - $12.7 Million
-468,893 Reduced 50.92%
451,882 $8.94 Million
Q1 2021

May 17, 2021

BUY
$18.57 - $25.68 $665,195 - $919,883
35,821 Added 4.05%
920,775 $21.4 Million
Q4 2020

Feb 16, 2021

BUY
$15.26 - $28.61 $3.23 Million - $6.06 Million
211,767 Added 31.46%
884,954 $18.4 Million
Q3 2020

Nov 16, 2020

SELL
$20.58 - $28.96 $11.2 Million - $15.8 Million
-544,594 Reduced 44.72%
673,187 $14.6 Million
Q2 2020

Aug 14, 2020

SELL
$11.15 - $24.64 $3.05 Million - $6.73 Million
-273,146 Reduced 18.32%
1,217,781 $28.7 Million
Q1 2020

May 14, 2020

SELL
$8.75 - $16.3 $9.46 Million - $17.6 Million
-1,080,630 Reduced 42.02%
1,490,927 $17.6 Million
Q4 2019

Feb 14, 2020

BUY
$7.95 - $11.84 $4.6 Million - $6.85 Million
578,539 Added 29.03%
2,571,557 $27.3 Million
Q3 2019

Nov 14, 2019

BUY
$10.82 - $14.25 $312,524 - $411,597
28,884 Added 1.47%
1,993,018 $22.7 Million
Q2 2019

Aug 15, 2019

BUY
$7.95 - $11.25 $14.4 Million - $20.4 Million
1,809,333 Added 1168.81%
1,964,134 $22.1 Million
Q2 2019

Aug 14, 2019

SELL
$7.95 - $11.25 $6.12 Million - $8.65 Million
-769,200 Reduced 83.25%
154,801 $2.26 Million
Q1 2019

May 14, 2019

BUY
$5.95 - $10.19 $5.26 Million - $9.01 Million
884,297 Added 2227.22%
924,001 $7.48 Million
Q4 2018

Feb 14, 2019

SELL
$5.91 - $9.29 $1.12 Million - $1.76 Million
-189,213 Reduced 82.66%
39,704 $251,000
Q3 2018

Nov 14, 2018

SELL
$6.4 - $9.85 $1.49 Million - $2.29 Million
-232,816 Reduced 50.42%
228,917 $2.26 Million
Q2 2018

Aug 14, 2018

BUY
$6.9 - $9.9 $2.48 Million - $3.56 Million
359,561 Added 351.92%
461,733 $3.83 Million
Q1 2018

May 15, 2018

BUY
$7.2 - $10.05 $543,182 - $758,192
75,442 Added 282.24%
102,172 $736,000
Q4 2017

Feb 14, 2018

BUY
$7.25 - $15.65 $193,792 - $418,324
26,730
26,730 $218,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $5.22B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.